Antithrombotic Therapy in Patients With Thrombocytopenic Cancer
- 14 July 2014
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 20 (8) , 799-806
Abstract
Background: Guidelines are discordant concerning management of patients having thrombocytopenia with cancer-associated thrombosis (CAT). Methods: Hospitalized adults with CAT and platelets ≤50 × 109 cells/L were managed with dalteparin 100 units/kg subcutaneously once daily. Comparator patients with CAT and platelets >50 × 109 cells/L were managed with dalteparin 200 units/kg/d. Results: Outcomes of 35 patients with thrombocytopenia (mean platelet count 26 ± 8.3 × 109 cells/L) and 58 comparator patients (mean platelet count 155 ± 75 × 109 cells/L) were evaluated. In all, 2 (5.7%) patients in the thrombocytopenia group and 1 patient (1.9%) in the comparator group experienced new-onset venous thromboembolism (odds ratio 3.31, 95% confidence interval [CI] 0.29-37.90, P = .556). The incidence of bleeding in patients with thrombocytopenia (8.6%) was similar to that in comparator patients (9.4%; risk ratio 0.94, 95% CI 0.37-2.39, P = .607). Conclusion: In hospitalized patients having thrombocytopenia with CAT, reduced-dose low-molecular-weight heparin was generally efficacious.Keywords
This publication has 41 references indexed in Scilit:
- Increased Risk of Chemotherapy-Associated Venous Thromboembolism in Elderly Patients with CancerRejuvenation Research, 2013
- Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United StatesClinicoEconomics and Outcomes Research, 2013
- Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006British Journal of Cancer, 2010
- Venous thromboembolism and prognosis in cancerThrombosis Research, 2010
- Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJournal of Thrombosis and Haemostasis, 2007
- Chemotherapy-induced thrombosisThrombosis Research, 2006
- Malignancies, Prothrombotic Mutations, and the Risk of Venous ThrombosisJAMA, 2005
- Risk Factors for Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 2000
- Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims DataMedicine, 1999
- Activation of blood coagulation in cancer: Trousseau's syndrome revisitedBlood, 1983